UBS’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | $22K | Buy |
4,377
+1,452
| +50% | +$7.3K | ﹤0.01% | 5288 |
|
|
2014
Q2 | $40K | Sell |
2,925
-54,983
| -95% | -$752K | ﹤0.01% | 4791 |
|
|
2014
Q1 | $887K | Buy |
57,908
+55,581
| +2,389% | +$851K | ﹤0.01% | 2728 |
|
|
2013
Q4 | $18K | Buy |
2,327
+629
| +37% | +$4.87K | ﹤0.01% | 5272 |
|
|
2013
Q3 | $17K | Buy |
1,698
+1,281
| +307% | +$12.8K | ﹤0.01% | 5164 |
|
|
2013
Q2 | $2K | Buy |
+417
| New | +$2K | ﹤0.01% | 5958 |
|